📈 Today’s in-play stocks

Here are the big movers and why 💃                                                                                                                                                                                                                                                                                                                                                                                                                 *Together with Today’s Top Tech Stock – VUZI Good morning, 360! Here are our top investing ideas today – and check out our Market News towards the bottom. Be the best prepared trader on the Street! ATOM - Up 35% in pre-market after signing commercial license agreement with STMicroelectronics EVLO - Trades 69% higher in pre-market after FDA approves rival biotechs microbiome therapeutic UCAR - Up 25% in pre, after announcing that on Apr 25, 2023, WetPark Capital exercised its over-allotment option to purchase an additional 83,333 ordinary shares at the IPO price of $6 per share *A Message on Behalf of Technology Market Report 🔥 Hot Stock of the Day 🔥 Vuzix Corp (Nasdaq: VUZI) Today, we’ve found a perfect stock to look at. This one checks all of the boxes for us… Excellent technical trading chart… ✅ Loads of insider buying…✅ Serious institutional ownership. In fact, Cathie Wood’s ARK Funds are the largest owner with over a 10% interest! ✅ A very high-level of short interest…✅ And analysts are drooling over the stock. They have slapped an average price target over 200% higher than current levels…✅ We have been on a hot streak lately with featured ideas. Do yourself a favor and make sure you look into VUZI right now! As always, make sure you spend some time getting to know about the risks and potential rewards with any stock you trade and are comfortable with it. To get started, [check out this short report]( that our friends at Tech Market Report have put together. *Sponsored by Lifewater Media. Please see disclosures below. ATOM - Up 35% in pre-market after signing commercial license agreement with STMicroelectronics Atomera (ATOM), a semiconductor materials and technology licensing company, reported earnings of Q1 EPS -$0.21 vs -$0.17 expected. Despite the earnings miss, ATOM is up 35% in pre-market after signing a commercial license agreement with STMicroelectronics. This agreement enables ST to install Atomera's Mears Silicon Technology™ (MST®) into its facilities and authorizes ST to manufacture and distribute MST-enabled products to its customers. MST is a quantum-engineered material that enhances transistors to deliver significantly better performance in semiconductor devices, while shrinking die sizes and reducing cost in today's electronics. The $7 has been an area of support in the pre-market and will be an important level to watch. Above it, targets to the upside are $7.30, $7.70, $8, $8.40 and then the after-hours high of $8.77. Beyond that targets are $9 and $10. Below $7, there is potential support at $6.70, $6, $5.50 and a gap to fill at $5.22. EVLO - Trades 69% higher in pre-market after FDA approves rival biotechs microbiome therapeutic Seres Therapeutics (MCRB) was up 11% reported FDA approval of SER-109, an oral microbiome therapeutic to prevent the recurrence of C. difficile infection (CDI). However after the news, EVLO – a rival biotech focused on microbiome-based therapeutics – exploded over 69% in the pre-market. EVLO stock was down over 30% yesterday after its phase 2 study did not meet its endpoint. However, the sympathy trade is strong today after MCRB’s release and EVLO has found buyers. Morgan Stanley also maintained a hold rating on EVLO and kept its $2 representing significant upside. EVLO found some buyers at $0.1650 in pre-market so that will be an important level to watch. Above it, targets to the upside are $0.20, $0.22, $0.2450, $0.27, $0.29 and then the pre-market high at $0.3170. Beyond that, targets are at $0.40 and $0.48. Below $0.1650, there is potential support at $0.15, $0.1375 and a gap to fill at $0.10. UCAR - Up 25% in pre, after announcing that on Apr 25, 2023, WestPark Capital exercised its over-allotment option to purchase an additional 83,333 ordinary shares at the IPO price of $6 per share U Power (UCAR) is a recent IPO that ran to over $70 last week. It has since cratered to close at $4.07 below its IPO price of $6. Despite the drop below IPO price, WestPark Capital exercised its over-allotment option to purchase an additional 83,333 ordinary shares at the IPO price of $6 per share. UCAR is up 25% this morning on the news. $5 was a resistance area in the pre-market and now that UCAR has broken through it, it becomes potential support. Above it, targets to the upside are $5.50, and then the IPO price of $6. Beyond that targets are $7, $8 and $10. Below $5, there is potential support at $4.80, $4.60, $4.50 and $4.30 with a gap to fill at $4.07. Economic Calendar (EST) 8:30am GDP 8:30am Jobless claims 10:00am Pending home sales 10:30am EIA Nat Gas Report No Fed Speakers scheduled Earnings for Today (After Market) ABCB, ACA, ACCD, AEM, AJG, ALSN, AMGN, AMZN, APPF, ASND, ATR, ATVI, AX, AXTI, AYX, BAFN, BFST, BJRI, BRFH, BVN, BWMX, BY, BZH, CAMP, CBAN, CC, CINF, COF, COLM, COUR, CPT, CSL, CTO, CUBE, CUBI, CUZ, CVLG, CVRX, CWST, DAIO, DLR, DXCM, EBC, EGO, EHC, EIG, EKSO, ELME, EMN, ERIE, ESS, EVBN, EXPO, FE, FHI, FICO, FINW, FLIC, FRST, FSLR, GFL, GILD, GLPI, HIG, HUBG, IMAX, INT, INTC, IVT, JAKK, KN, KNSL, LADR, LHX, LPLA, LTC, MATW, MBIN, MDLZ, MHK, MOFG, MSBI, MTX, MYFW, NET, NEXA, NWE, OFC, OIS, OLN, ORC, PEAK, PFG, PFS, PINS, PTCT, RMD, ROG, RSG, RWT, SAM, SBCF, SGEN, SKT, SKX, SKYW, SLCA, SM, SNAP, SPFI, SSB, SSNC, STRT, SWN, TBBK, TBNK, TMUS, TUSK, ULH, USCB, UVE, VRSN, WY, X, ZYXI Top Headlines FCPT FCPT Announces Acquisition of an Arby’s Property for $1.2 Million META will layoff more workers in May. PANL Pangaea Logistics Solutions Ltd. Adds Capacity with the Acquisition of Dry Bulk Vessel SUAC ShoulderUp Technology Acquisition Corp. Announces Stockholder Approval of Extension Amendment to the Amended and Restated Certificate of Incorporation and Investment Management Trust Agreement SIX Six Flags Announces Pricing of $800 Million of 7.250% Senior Notes due 2031 U.S. House narrowly passes Republicans’ debt ceiling bill that aims to spark negotiations with Biden on avoiding default – Reuters VNO Vornado Announces Postponement of Common Share Dividends Until Year-End and Authorization of $200 Million Share Repurchase Program MCRB FDA Approves First Orally Administered Fecal Microbiota Product for the Prevention of Recurrence of Clostridioides difficile Infection sm ESLT Elbit Systems Signs Follow-On Contract Worth Approximately $100 Million to Provide Firefighting Squadron Services to the Israeli Ministry of National Security XOM Exxon oil worker strike in Nigeria has been called off – nnpc LODE Comstock Advances Purchase and Sale of Facility BNOX Bionomics Announces the Completion of Enrollment in Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD) RMTI Rockwell Medical's Partner Drogsan Pharmaceuticals Submits Marketing Authorization Application in Turkey for Triferic AVNU SMMF Summit Financial Group Reports First Quarter 2023 Earnings of $1.08 Per Share, Fueled by Continued Loan and Deposit Growth, and Improved Net Interest Margin APCX AppTech Payments Corp. and Corix Solutions Announce Strategic Partnership to Accelerate the Waves Enterprise Blockchain Mobile Payment Capabilities AMAL: Amalgamated Financial Corp. Reports First Quarter 2023 Financial Results; Exhibiting Deposit Stability and Solid Liquidity AULT: Ault Alliance’s Subsidiary, Ault Global Real Estate Equities, Unveils Four Newly Renovated Hotels with Grand Re-Openings ARES US Heart & Vascular Expands to Kansas through Partnership with Heartland Cardiology JEF Jefferies and SMBC Expand and Strengthen Strategic Alliance, Broadening Joint Business Efforts and Increasing SMBC’s Equity Ownership in Jefferies DGX: Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio MBLY - Mobileye lowers its annual revenue forecast due to the reduction in EV demand in China. Number of headwinds affecting the market SMR NuScale Receives International Organization for Standardization (ISO) Certification, the Global Standard for Quality Management Systems ICPT: Intercept Announces New Data to be Presented at The European Association for the Study of the Liver (EASL) Congress 2023 and Provides Update on OCA-bezafibrate Fixed-Dose Combination (FDC) Development Program MMM: Two 3M Veraflo Therapy dressings receive first-ever FDA clearance for hydromechanical removal of non-viable tissue BCRX BioCryst Presents New Long-term Data Demonstrating Consistently High Attack-free Status Among Hereditary Angioedema Patients with ORLADEYO® (berotralstat) TLSA Tiziana Life Sciences Announces Findings from Intranasal Anti-CD3 mAb Treatment in Intracerebral Hemorrhage at the Annual American Academy of Neurology Conference ANVS Annovis Bio Announces Issuance of U.S. Patent Covering the Use of Lead Drug Candidate, Buntanetap, for Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis in Healthy or Sick Humans PLUR Cell Manufacturing Pioneer, Pluri Inc., Unveils PluriMatrix: a Breakthrough System for Unprecedented Industrial Scale Production of Cell-Based Products HWEL Starton Therapeutics Inc. and Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer Treatments MITQ Moving iMage Technologies Announces New Esports Orders From SNDBX For Eight EVO Entertainment Group Locations EVGN Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital MCRB Announces $250 Million Debt Financing with Oaktree. To receive proceeds of $110 million upon closing of the agreement To Your Success! *please see disclosures below Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions *PAID ADVERTISEMENT. RagingBull has been paid fourteen thousand dollars by ach bank transfer by Lifewater Media for advertising Vuzix Corporation from a period beginning on April 27, 2023 through April 28 of the same year. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of Raging Bull, do not hold a position in Vuzix Corporation. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Vuzix Corporation, increased trading volume, and possibly an increased share price of the BVuzix Corporation securities, which may or may not be temporary and decrease once the marketing arrangement has ended. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. A portion of our business is engaged in the marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. A portion of RagingBull’s business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, SMS, push notifications. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the corporate awareness program ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is not currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https:// www.sec. gov/ edgar/searchedgar/ companysearch WE MAY HOLD SECURITIES DISCUSSED. Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States [[beehiiv logo]Powered by beehiiv](